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The cellular and molecular mechanisms mediating
histamine-independent itch in primary sensory
neurons are largely unknown. Itch induced by chloro-
quine (CQ) is a common side effect of this widely
used antimalarial drug. Here, we show that Mrgprs,
a family of G protein-coupled receptors expressed
exclusively in peripheral sensory neurons, function
as itch receptors. Mice lacking a cluster of Mrgpr
genes display significant deficits in itch induced by
CQ but not histamine. CQ directly excites sensory
neurons in an Mrgpr-dependent manner. CQ specif-
ically activatesmouseMrgprA3 and humanMrgprX1.
Loss- and gain-of-function studies demonstrate
that MrgprA3 is required for CQ responsiveness in
mice. Furthermore, MrgprA3-expressing neurons
respond to histamine and coexpress gastrin-releas-
ing peptide, a peptide involved in itch sensation,
and MrgprC11. Activation of these neurons with the
MrgprC11-specific agonist BAM8-22 induces itch in
wild-type but not mutant mice. Therefore, Mrgprs
may provide molecular access to itch-selective
neurons and constitute novel targets for itch thera-
peutics.INTRODUCTION
Itch, formally known as pruritus, has been defined as an
‘‘unpleasant skin sensation that elicits the desire or reflex to
scratch’’ (Ikoma et al., 2006). Primary sensory neurons in dorsal
root ganglia (DRG) play an essential role in generating itch byCdetecting pruritogenic stimuli through their peripheral axons in
the skin and mucosal surfaces and sending the signals to the
spinal cord via their central axons (Paus et al., 2006). The best-
characterized itch mediator is histamine, which is mainly
secreted by skin mast cells and excites nearby sensory fibers
by acting on histamine receptors (Alving et al., 1991). Hista-
mine-induced itch in humans can be almost completely blocked
by histamine receptor H1 antagonists. However, the blockers are
ineffective in many other itch conditions, such as those arising
from atopic dermatitis, renal and liver diseases, the side effects
of drugs, plant toxins, and mechanical stimuli (Paus et al., 2006).
These observations, together with other electrophysiological
and molecular studies, strongly imply the existence of hista-
mine-independent types of itch (Davidson et al., 2007; Johanek
et al., 2007; Johanek et al., 2008). A major hurdle to investigating
histamine-independent itch is the lack of information about
the receptors directly activated by nonhistaminergic pruritogens,
as well as molecular markers for itch-sensing neurons in the
DRG.
Chloroquine (CQ) is a drug that has long been used in the treat-
ment and prevention of malaria. One major side effect of this
drug is itch, which is very common among black Africans (up
to 70%) but less common in other races. Pruritus is a major
cause of noncompliance in the treatment of malaria as 30%
of African patients refused further CQ treatment because of
unbearable itch (Mnyika and Kihamia, 1991; Sowunmi et al.,
2000). This noncompliance may lead to the development and
spread of CQ-resistant Plasmodium falciparum. CQ-induced
itch is not considered an allergic reaction since pruritus is seen
after first exposure (Ademowo et al., 1998; Olatunde, 1977).
More importantly, it cannot be treated effectively by antihista-
mine drugs, suggesting that a histamine-independent pathway
is involved (Abila et al., 1994; Ezeamuzie et al., 1990). CQ-
induced itch is also well documented in mice. Subcutaneous
CQ injection inwild-type (WT)mice acutely evokes a pronouncedell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc. 1353
scratching behavior (Green et al., 2006). Interestingly, mice lack-
ing gastrin-releasing peptide receptor (GRPR), which is specifi-
cally expressed in dorsal horn neurons of the spinal cord, exhibit
severely reductions in itch responses evoked by various prurito-
gens, including CQ (Sun and Chen, 2007). Furthermore, mice
with GRPR-expressing dorsal horn neurons selectively ablated
showed profound scratching deficits, whereas pain behaviors
were unaffected in these animals (Sun et al., 2009). These
findings suggest that both GRPR and the second-order neurons
in the spinal cordmarked by GRPR are important for transmitting
itch signals from primary sensory afferents. However, it is
unknown whether CQ directly activates primary sensory fibers
in the skin and whether cell surface receptors are involved in
the process.
Several G protein-coupled receptors (GPCRs) have been
shown to be essential in generating itch, including histamine
receptors and protease-activated receptors (PARs) (Shim and
Oh, 2008; Steinhoff et al., 2003). Mrgprs (also named Mrg/
SNSR) are a family of orphan GPCRs consisting of more than
50 members in the mouse genome that can be grouped into
several subfamilies: MrgprA1–A22, MrgprB1–B13, MrgprC1–
C14, and MrgprD–G (Dong et al., 2001; Zylka et al., 2003). Strik-
ingly, the expression of Mrgprs, including MrgprAs, MrgprB4,
MrgprB5, MrgprC11, and MrgprD, is restricted to subsets of
small-diameter sensory neurons in DRG and trigeminal ganglia
and has not been detected in the central nervous system or in
the rest of the body (Dong et al., 2001; Zylka et al., 2003). Simi-
larly, human MrgprXs are also selectively expressed in DRG
neurons (Lembo et al., 2002).
Mrgprs can be activated by peptides terminating in RF/Y-G or
RF/Y-amide, such as molluscan FMRFamide and mammalian
neuropeptide FF (NPFF), neuropeptide AF (NPAF), g2-melano-
cyte-stimulating hormone (g2-MSH), and bovine adrenalmedulla
peptide (BAM). These peptides can activate heterologously
expressedmouseMrgprA1,MrgprA4, andMrgprC11 and human
MrgprX1 with different sensitivities (Dong et al., 2001; Han et al.,
2002; Lembo et al., 2002). The highly restricted expression of
these receptors suggests that Mrgprs are likely to be involved
in somatosensation, including pain or itch, but direct evidence
for this is lacking. Here, we demonstrate that certain Mrgprs
function as receptors for CQ and mediate its direct activation of
a small subset of DRG neurons and CQ-induced itch. More
importantly, CQ-sensitive neurons, comprising only 4%–5% of
total DRG neurons, may define a subpopulation of DRG neurons
that mediate itch.
RESULTS
Targeted Deletion of a Cluster ofMrgpr Genes
Many Mrgpr genes are clustered together on mouse chromo-
some 7 (Dong et al., 2001; Zylka et al., 2003). To determine the
function of Mrgprs in vivo while overcoming the potential
problem of gene redundancy, we generated a mouse line in
which a cluster of Mrgpr genes was deleted (Figures 1A and
1B). The deleted 845 kilobase region comprises 30 Mrgpr
genes, 12 of which (MrgprA1–A4, A10, A12, A14, A16, A19,
B4, B5, and C11) have intact open reading frames (ORFs;
Figure 1A). No other ORF is present in this region, according1354 Cell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc.to the Mouse Genome Project. Although the mouse Mrgpr
superfamily consists of over 50 members, more than half are
pseudogenes, and only 24 genes have intact ORFs (Dong
et al., 2001; Han et al., 2002). Therefore, the deleted cluster
represents 50% of the potentially functional Mrgpr repertoire
and contains most MrgprA and MrgprC genes, as well as
some members of the MrgprB subfamily. The deleted Mrgpr
genes are specifically expressed in DRG (Dong et al., 2001;
Han et al., 2002; Zylka et al., 2003). MrgprA6, A9, A11, B1, B2,
B6, B8, B10, and D–G are not included in this deletion based
on the Mouse Genome Project and RT-PCR experiments (data
not shown). Notably, MrgprB1 and MrgprB2, which were not
deleted, are expressed in the skin but not in DRG (Zylka et al.,
2003).
Mating between mice heterozygous for the cluster deletion
(Mrgpr-clusterD/+) produced offspring with the expected
Mendelian distribution of gender and genotype. Homozygous
Mrgpr-clusterD/mice are viable, fertile, and generally indistin-
guishable fromWT littermates in appearance, bodyweight, overt
behavior, and gross anatomy. The motor function of Mrgpr-
clusterD/ mice is also normal as determined by the rotarod
test (data not shown). Furthermore, Mrgprs are not required for
neuronal survival, fate determination or differentiation of small-
diameter sensory neurons (Figure 1C; Supplemental Data avail-
able online).
Mrgpr-clusterD/ Mice Exhibit Severe Reduction
in CQ-Induced Scratching
Activation of small-diameter sensory neurons in DRG can
generate different types of somatosensation, including pain and
itchwith specific anddistinct behavioral responses. For instance,
pain and itch cause withdrawal and scratching responses,
respectively (Ikoma et al., 2006). We next investigated whether
the deletion of Mrgpr genes affects behavioral responses
to pain- and itch-inducing stimuli. Mrgpr-clusterD/ mice
responded normally to acute noxious heat, cold, mechanical,
and chemical stimulation as compared with WT littermates
(Figures 2A–2F). Thus, acute pain sensation appears to be unaf-
fected inMrgpr-clusterD/mice. In addition,Mrgprmutantmice
exhibited modest but statistically significant increases only at
certain testing time points in inflammatory hyperalgesia induced
by complete Freund’s adjuvant (CFA) or carrageenen injection.
No significant difference was found in neuropathic pain caused
by L5 spinal nerve ligation between mutant and wild-type mice
(Figure S1).
In addition to pain, we evaluated chemically induced itch
responses in Mrgpr-clusterD/ mice. No significant difference
was found between Mrgpr-clusterD/ and WT mice in the total
number of scratching bouts induced by histamine over a period
of 30 min (Figure 2G). Consistent with this result, WT and mutant
mice also showed similar responses to compound 48/80, a drug
that elicits mast cell degranulation and induces histamine-
dependent itch (Kuraishi et al., 1995; Nakayama et al., 2002)
(Figure 2H). These results suggest that Mrgprs are not involved
in histamine-dependent itch.
Strikingly, itch induced by CQ was strongly reduced inMrgpr-
clusterD/ mice. Figure 2I shows the time course of scratching
bouts at 5min intervals after CQ injection. Typically, the first bout
Figure 1. Targeted Deletion of a Cluster of Mrgpr Genes
(A) Top horizontal line represents Mrgpr gene cluster on WT mouse chromosome 7. The distance between MrgprA1 and MrgprB4 is 845 kilobases, which
contains 12 intactMrgprs (each represented by a black bar with its name on top). Targeting constructs containing loxP sites (black triangles), and the selection
marker genes were introduced to theMrgprA1 andMrgprB4 loci in embryonic stem cells (ESCs) by two rounds (1st and 2nd) of electroporation and homologous
recombination. Positive ES clones with correct targeting in the two loci underwent a third round of electroporation with CMV-Cre construct. Cre-mediated
recombination resulted in deletion of an Mrgpr cluster between loxP sites. The deletion event in ESCs (lanes 1 and 2; lane 3 as negative control with WT
ESCs) was detected by PCR amplification with primers 1 and 2 flanking the cluster (shown as arrowheads). The PCR product (456 bp) was further confirmed
by sequencing.
(B) Southern blot of genomic DNA with anMrgprA orMrgprC probe. The genomic DNA was digested with BglII. Because of cross-hybridization, a singleMrgprC
or MrgprA probe can label multiple members of the MrgprC or MrgprA subfamily in WT (+/+) and cluster heterozygous mice (+/) DNA. In homozygous mice
(/), most of the positive bands are absent (arrows).
(C) The deletion of Mrgpr genes does not affect cell fate determination of small-diameter sensory neurons. The proportion of nonpeptidergic (IB4+) and pepti-
dergic (CGRP+) small-diameter sensory neurons does not differ between WT and Mrgpr-clusterD/ mice (n = 3).was observed within 1 to 2 min after injection, and scratching
peaked within 15 min in WT mice. In contrast, Mrgpr-
clusterD/ mice showed a delayed occurrence of the first
scratching behavior (WT 57.8 ± 25.4 s versus KO 280.5 ± 35.0 s;
p = 0.0004). The total number of scratching bouts induced by
CQ was 278 ± 21 in WT mice and 104 ± 13 inMrgpr-clusterD/
mice (Figure 2I). Interestingly, injection of a CQ precursor,
quinoline, did not evoke any scratching behavior (see below for
quinoline’s structure and inability of activating Mrgprs) in both
WT and mutant mice (Figure 2J). However, immediately after
quinoline treatment, CQ injection at the same location induced
robust scratching behavior in WT mice, and the number of
scratches induced by this treatment was again severely reduced
inMrgpr-clusterD/mice (Figure 2J). These results suggest that
CQ-induced itch, but not histaminergic itch, is affected in the
cluster deletion mice. Similarly, intradermal injection of CQ in
rats evoked profound scratching responses, whereas quinolineCdid not (Figure S2A). These data provide further evidence that
CQ-evoked itch is well conserved.
Previous studies have indicated that CQ can cause mast cell
degranulation (Green and Lim, 1989; Nosal et al., 1991). To
determine whether this effect on mast cells contributes to
CQ-evoked scratching behavior, we repeated the experiment
on SASH mice, which lack mast cells due to a chromosomal
inversion in the regulatory element of the Kit gene (Yamazaki
et al., 1994). As compared to WT controls, SASH mice
exhibited a modest but significant reduction in CQ-induced
scratching behavior (Figure 2K). The mast cell deficiency in
these mice was confirmed by a dramatic decrease in the level
of histamine released upon skin mast cell degranulation
(Figure 2L). These results confirm that degranulation of mast
cells induced by CQ contributes to scratching behavior, which
may account for the residual response to CQ in Mrgpr-
clusterD/ mice.ell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc. 1355
Figure 2. Mrgpr-clusterD/ Mice Show Severe Deficiency in CQ-Induced Itch
(A–D)Mrgpr-clusterD/mice respond normally to noxious acute thermal stimuli. Response latencies in tail immersion (50C, n = 12 per genotype, A), hot-plate
(50C, n = 11 per genotype, B), Hargreaves (n = 24 per genotype, C) and cold-plate (0C, WT n = 13, KO n = 9, D) tests did not differ between WT and Mrgpr-
clusterD/ mice.
(E) The paw withdrawal threshold ofMrgpr-clusterD/mice to punctate mechanical stimuli (Von Frey) was comparable to that of WTmice (n = 12 per genotype).
(F) Mrgpr-clusterD/ mice responded normally to noxious acute chemical stimuli. The writhing responses to intraperitoneal injection of acetic acid (0.6%,
15 ml/kg) were indistinguishable between WT and Mrgpr-clusterD/ mice (n = 12 per genotype).
(G and H)Mrgpr-clusterD/mice displayed normal histamine-dependent itch. The total scratching bouts were not significantly different betweenWT andMrgpr-
clusterD/mice during the first 30 min after subcutaneous injection of histamine (10 mmol; WT n = 7, KO n = 10, G) or compound 48/80 (100 mg/50 ml; WT n = 8,
KO n = 7, H).
(I)Mrgpr-clusterD/mice showed deficiency in CQ-induced itch. The total scratching bouts during the first 30 min after CQ injection (200 mg/50 ml, 8 mM) were
significantly decreased in Mrgpr-clusterD/ mice (n = 9) compared to WT littermates (n = 8). The time course shows bouts of scratching at 5 min intervals.
(J) Quinoline (QN) failed to induce itch in both WT andMrgpr-clusterD/ mice. However, subsequent injection of CQ induced a strong scratch response in WT
and a much weaker response in Mrgpr-clusterD/ mice (n = 5 per genotype).
(K) SASH mice showed a mild but significant reduction in CQ-induced itch compared with WT mice (SASH n = 8, WT n = 7).
(L) SASH mice released significantly less histamine than WT mice after IgE stimulation of the skin (n = 5 per genotype), which provides strong evidence for the
mast cell deficiency in SASH mice. The data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.005; two-tailed unpaired t test or two-way ANOVA.CQ Directly Excites DRG Neurons in an
Mrgpr-Dependent Manner
Since CQ-induced itch is not considered an allergic reaction, we
hypothesized, given our results, that this type of itch results from
a direct activation of DRG neurons by the drug. If so, then the
behavioral deficit seen in mutant mice would be attributed to
a loss of CQ responsiveness in primary sensory neurons. Indeed,
1 mM CQ treatment of cultured DRG neurons evoked a robust
intracellular calcium ([Ca2+]i) increase in 4%–5% of the cells
from WT mice. In contrast, none of the neurons in cultures
derived from Mrgpr-deficient mice exhibited any significant
response to CQ (Figure 3B). These data indicate that the
CQ-evoked [Ca2+]i increases seen in WT DRG cultures reflect
specific activation of a subset of cells and that this activation is
Mrgpr dependent. In contrast, the percentage of DRG neurons
responding to histamine was identical between WT and mutant
cultures, consistent with the behavioral data and providing
further evidence that histamine-induced itch is unaffected in
Mrgpr-clusterD/ mice (Figure 3A).
We performed additional experiments to further characterize
[Ca2+]i increases in WT neurons. Sequential application of CQ1356 Cell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc.caused an 20% reduction of calcium responses. In addition,
extracellular Ca2+ was necessary for the CQ-induced increase
in [Ca2+]i since the CQ effect was almost completely blocked in
Ca2+-free bath solution. Ruthenium red, an inhibitor of several
TRP channels (Fujita et al., 2007), also severely attenuated the
effect, indicating that TRPs are likely to be involved in the CQ
signaling pathway (Figures 3C and 3D). Signaling via TRP
channels has been observed for many GPCRs in DRG neurons,
including the histamine and bradykinin receptors (Chuang et al.,
2001; Shim et al., 2007).
We also examined whether CQ can directly induce action
potentials (APs) in dissociated DRG neurons, using whole-cell
patch clamp recording. In WT DRG, all CQ-sensitive neurons
(identified by calcium imaging) displayed a train of APs upon
subsequent CQ treatment (Figure 3E). In contrast, all neurons
that fail to show a calcium response to CQ also failed to generate
APs with a similar treatment (n = 14). As in the calcium-imaging
experiments, none of 11 size-matched neurons (diameter of
20 mm) tested from Mrgpr-clusterD/ mice showed any
response to the drug. These studies provide strong evidence
that CQ can directly excite a small subpopulation of sensory
Figure 3. The Response of DRG Neurons to
CQ Is Mrgpr Dependent
(A) The response to histamine was not impaired in
Mrgpr-deficient DRG neurons. Calcium imaging
showed that the percentage ofMrgpr-clusterD/
DRG neurons responding to histamine (50 mM)
was similar to that of WT neurons (n = 3 per geno-
type).
(B) Approximately 4.4% of WT DRG neurons re-
sponded to CQ (1 mM) with increased [Ca2+]i
whereas Mrgpr-clusterD/ DRG neurons failed
to respond to the drug (n = 3 per genotype).
(C and D) Extracellular calcium was required for
the CQ-induced [Ca2+]i increase in DRG neurons.
(C) Representative traces from three different DRG
neurons in calcium-imaging assays. The CQ-
induced increase in [Ca2+]i was almost completely
blocked with EGTA treatment. Ruthenium red (RR)
also significantly attenuated [Ca2+]i increase
evoked by CQ. As a control, sequential treatment
of CQ only caused an 20% reduction in [Ca2+]i
increase.
(D) Quantification of calcium-imaging assays. At
least 20 CQ-sensitive neurons were analyzed for
each experiment.
(E) CQ (1 mM) induced APs in DRG neurons. In WT
DRG neurons, all CQ-sensitive neurons (as deter-
mined by calcium imaging, n = 5) elicited a train of
APs evoked by subsequent CQ treatment. In
contrast, none of the neurons tested (n = 11)
from Mrgpr-clusterD/ mice showed any
response to the drug.
All error bars represent the SEM.neurons in DRG and that Mrgprs are required for this effect.
Similar to the mouse results, CQ induces robust activation in
a subset of rat DRG neurons as determined by both an increase
in [Ca2+]i and generation of APs (Figure S2).
CQ Specifically Activates Mouse MrgprA3 and Human
MrgprX1
The Mrgpr-clusterD/ behavioral and cellular loss-of-function
phenotypes strongly suggest that Mrgprs function as cell-
surface receptors for CQ. To test this possibility directly, we
examined whether Mrgprs have the ability to confer sensitivity
to CQ on heterologous cells. We cloned each of the 12 Mrgprs
that were deleted in Mrgpr-clusterD/ mice (Figure 1A) into
a mammalian expression vector and transfected them individu-
ally into human embryonic kidney (HEK) 293 cells. By fusingCell 139, 1353–1365, Degreen fluorescent protein (GFP) to the
C termini of the Mrgpr coding sequences,
we were able to visualize both trans-
fected cells and the proper membrane
localization of the receptors. Our previous
studies demonstrated that GFP does not
disturb the normal function of Mrgprs
(Dong et al., 2001; Han et al., 2002).
Increased [Ca2+]i resulting from activation
of the receptors was monitored by
calcium imaging. Among the 12 mouseMrgprs, only MrgprA3 conferred a strong response to CQ on
HEK cells, whereas the other receptors conferred either weak
or no responses to the drug (Figures 4A–4D and 5B, and data
not shown). MrgprA1, MrgprA4, and MrgprC11 were activated
by their peptide agonists FMRF, NPFF, and BAM8-22, respec-
tively, confirming that they are functional receptors but insensi-
tive to CQ (Figures 4A, 4C, and 4D). Furthermore, MrgprA3-
expressing HEK cells did not respond to BAM8-22 or histamine,
indicating that MrgprA3 is a specific receptor for CQ (Figure 4B).
Conversely, histamine receptor H1-expressing HEK293 cells
failed to show any response to CQ (Figure 4F).
The human Mrgpr family (i.e., MrgprXs) is much smaller than
the murine family. Although the human and mouse genes
share strong sequence homology, they do not form clear orthol-
ogous pairs. We found that MrgprX1-expressing HEK293 cellscember 24, 2009 ª2009 Elsevier Inc. 1357
Figure 4. Mouse MrgprA3 and Human MrgprX1 Are the Predominant Receptors for CQ
HEK293 cells were transfected with expression constructs for Mrgprs and histamine H1 receptor. The effects of different agonists on these transfected cells were
tested via calcium imaging. Each figure shows a typical response from three different cells.
(A) Fewer than half of MrgprA1-tranfected cells responded to CQ (1 mM) with increased [Ca2+]i whereas all transfected cells responded to FMRF (2 mM).
(B) All MrgprA3-expressing cells responded to CQ but not histamine.
(C) MrgprA4-expressing cells respond to NPFF (2 mM) but not CQ.
(D) MrgprC11-expressing cells failed to respond to CQ whereas they responded to BAM8-22 (2 mM).
(E) Human MrgprX1 responded to both CQ and BAM8-22 (2 mM).
(F) Cells expressing the histamine H1 receptor exhibited a strong response to histamine (50 mM) but failed to respond to CQ.responded to CQ, whereas MrgprX2- and X3-expressing cells
were completely insensitive to the drug (Figure 4E and data not
shown). Together, these data suggest that CQ directly activates
mouse MrgprA3 and human MrgprX1 in heterologous cells with
high specificity.
In order to determine the lowest concentrations of CQ capable
of activating MrgprA3 and X1, we performed dose-response
experiments in HEK293 cells. These experiments indicated
that the receptors could be activated by the drug at micromolar
concentrations with the mouse receptor showing 10-fold higher
sensitivity than the human receptor (Figure 5B and 5D). EC50s for
MrgprA3 and MrgprX1 are 27.55 ± 2.03 and 297.68 ± 2.10 mM,
respectively (see the Discussion regarding the low potency of
CQ on MrgprX1). Besides CQ, we also determined the sensitiv-
ities of these receptors to other structurally related compounds
(i.e., quinoline, quinine, and serotonin) (Figure 5A). Quinoline is
used as an intermediate in the production of various compounds
including CQ. Despite the presence of a bicyclic structure, quin-
oline completely failed to activate MrgprA3 and MrgprX1, sug-
gesting that the side chain in CQ is also necessary for activation
(Figures 5B and 5D). Consistently, quinoline does not induce
any scratching behavior in mice (Figure 2J). Serotonin also has
a bicyclic structure. But, unlike CQ or quinoline, its bicyclic struc-
ture consists of a six-membered benzene ring fused to a five-
membered nitrogen-containing pyrrole ring (Figure 5A). Sero-1358 Cell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc.tonin failed to activate MrgprA3 at a concentration of 100 mM
(Figure 5B). Quinine is another drug used to treat malaria, and
its side effects also include itch. However, it is unclear whether
quinine-induced itch is an allergic response (Gonzalez et al.,
2002; Kanny et al., 2003). Unlike CQ, quinine weakly activates
MrgprA3 (Figure 5B).
MrgprA3 Is the Major Receptor Mediating CQ
Responsiveness in DRG Neurons
We and other groups have shown that MrgprA3 is expressed in
a small subset (i.e., 4%–5%) of WT DRG neurons (Dong et al.,
2001; Liu et al., 2008; Zylka et al., 2003). The population of
MrgprA3+ neurons is small in comparison to that expressing
another Mrgpr member, MrgprD (Figure 6A). According to our
previous studies, MrgprA3 has the highest expression level
among all MrgprAs in adult mouse DRG, whereas MrgprA1 is
dramatically downregulated to expression in few neurons, all of
which are also MrgprA3+ (Zylka et al., 2003). To confirm the
expression profile ofMrgprA3, we performed RT-PCR on various
adult mouse tissues. Among the tissues tested, MrgprA3 is
found exclusively in DRG and nodose ganglia (Figure 6B). The
low intensity of the MrgprA3 band as compared to that of
GAPDH is consistent with the fact that only a small percentage
of neurons express MrgprA3 in these ganglia. Human MrgprX1
exhibits a similar expression pattern (Lembo et al., 2002). This
Figure 5. Mrgprs Are Selectively Activated by CQ
(A) Molecules with structures related to CQ.
(B–D) Dose-response curves for MrgprA3 (B), MrgprA1 (C), and MrgprX1 (D) expressed in HEK293 cells to the molecules in (A). Each data point represents the
mean ± SEM of at least three independent experiments, and at least 50 GFP+ cells were analyzed each time. Calcium responses at each ligand concentration
were normalized to the maximal response subsequently elicited.result also suggests that mast cells are unlikely to express
MrgprA3. We did not see MrgprA3 in the skin, which contains
many mast cells, nor did we seeMrgprA3 expression in primary
mast cells enriched from skin (Figure 6B) or bone marrow-
derived mast cells (data not shown). Therefore, the transmission
of CQ-induced itch signal by MrgprA3 likely occurs in primary
sensory neurons in DRG and not other cell types in the skin.
To determine whether the expression of MrgprA3 in DRG
neurons correlates with CQ sensitivity (also 4%–5%), we per-
formed single-cell RT-PCR for the gene on individual DRG
neurons responsive to CQ as determined by calcium imaging.
Eight out of nine CQ-responding neurons expressed MrgprA3
mRNA, whereas none of the 11 CQ-insensitive neurons showed
detectable levels of the receptor transcript (Figure 6C). Since
MrgprA3 expression in mouse DRG neurons correlates very
well with CQ sensitivity, we examined whether specific knock-
down of MrgprA3 would abolish CQ responsiveness. Strikingly,
WT DRG neurons failed to respond CQ after electroporation
with siRNA specifically targeted against MrgprA3, whereas a
control siRNA had no effect on CQ sensitivity (Figures 6D–6F).
These data strongly suggest that MrgprA3 is the main receptor
mediating CQ-evoked responses in mice. Unlike mouseMrgprA
subfamily which consists of 22 members, rats have only one
MrgprA. Consistently, using a single-neuron RT-PCR technique,
we found that all of CQ-sensitive rat DRG neurons express rat
MrgprA (n = 10).
MrgprA3 and MrgprX1 Rescue the Phenotypes
ofMrgpr-Deficient Neurons
We next asked whether MrgprA3 or MrgprX1 can rescue the
phenotypes of DRG neurons from Mrgpr-clusterD/ mice. ToCanswer this question, we electroporated the Mrgpr expression
constructs used in the heterologous studies into dissociated
adult DRG neurons from these mice. After 24 hr in culture,
expression andmembrane localization of the transfectedMrgprs
in the mutant neurons could be readily visualized by GFP
(Figure 6G). Strikingly, all MrgprA3-expressing mutant neurons
generated numerous APs in response to CQ treatment (Fig-
ure 6H), whereas neighboring GFP-negative neurons remained
silent (n = 6, not shown). The number of APs generated in the
GFP-positive neurons was comparable to that produced by
CQ treatment of WT DRG neurons, indicating a nearly complete
rescue by MrgprA3. Similar results were obtained for Mrgpr-
deficient neurons electroporated with MrgprX1 (Figure 6J). In
contrast, fewer than half of theMrgprA1-electroporated neurons
elicited a few APs in response to CQ (Figure 6I). Rescue by
MrgprA3 and MrgprX1 was also seen using calcium imaging,
with an increase in [Ca2+]i induced by CQ (Figures 6K–6M).
Together, these results strongly suggest that mouse MrgprA3
and human MrgprX1 are the major CQ receptors in DRG
neurons. Expression of rat MrgprA in Mrgpr-clusterD/ DRG
neurons conferred CQ sensitivity upon them, whereas rat
MrgprC did not (Figures S2D and S2E).
CQ-Sensitive Neurons Also Respond to Histamine
and Capsaicin
To further define the population of CQ-sensitive neurons in
DRG, we examined the responses of these cells to other well-
characterized chemicals. Many studies utilizing multiple
approaches have shown that histamine- and capsaicin-
responding cells largely overlap (Schmelz et al., 2003; Shim
et al., 2007). Consistent with previous reports, we found thatell 139, 1353–1365, December 24, 2009 ª2009 Elsevier Inc. 1359
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87% of histamine-sensitive DRG neurons also responded to
capsaicin as monitored by an increase in [Ca2+]i using calcium
imaging. Interestingly, all CQ-responding neurons in DRG
cultures were also activated by both histamine and capsaicin
(Figure 7A). Furthermore, we noticed that CQ-sensitive cells
have a narrow range of cell diameters, whereas histamine-
sensitive neurons have a wide range (Figure S3). Therefore,
the small population of CQ-sensitive neurons in WT DRG
defines a unique and specific subset of histamine- and capsa-
icin-sensitive neurons.
MrgprA3-Expressing Neurons Are Likely to Be
Itch-Selective Neurons
The finding that MrgprA3-positive neurons are sensitive to both
histamine and CQ raises the interesting possibility that these
neurons are itch-selective neurons. Gastrin-releasing peptide
(GRP), a ligand for GRPR, is expressed in a subset of DRG
neurons (Sun and Chen, 2007). To look for overlap between
GRP and MrgprA3 expression in DRG neurons, we carried out
double-staining experiments for these two genes. Strikingly,
93% of MrgprA3-positive neurons also expressed GRP,
providing strong evidence that MrgprA3-expressing neurons
may play important roles in itch sensation (Figures 7F and S4).
Our previous data have shown that expression of MrgprC11
largely overlaps with that ofMrgprA3 (Zylka et al., 2003). Consis-
tently, all BAM8-22-responsive neurons (i.e., 3.6% of total WT
DRG neurons) also responded to CQ (Figures 7C–7E). Impor-
tantly, no DRG neurons fromMrgpr-clusterD/mice responded
to BAM8-22 (Figure 7C). Aswe expected, intradermal injection of
BAM8-22 induced strong scratching behavior in WT mice,
whereas mutant mice exhibited a dramatic reduction in the
response evoked by the peptide (Figure 7B). Together, these
data suggest that activation of MrgprA3- or MrgprC11-express-
ing neurons by its specific agonist (i.e., CQ and BAM8-22,
respectively) can evoke scratching behavior and further support
that these neurons are involved in itch sensation.Figure 6. MrgprA3 Is Required for CQ Responsiveness in Mouse DRG
(A) Fluorescent in situ hybridization of DRG sections with MrgprA3 (green, arrow
(B) RT-PCR analysis of 14 mouse tissues or cell types for expression ofMrgprA3. T
no band was found in Mrgpr-clusterD/ DRG, confirming that MrgprA3 was de
(C) Single-cell RT-PCR was performed on individual DRG neurons with the res
12 representative neurons).MrgprA3mRNAwas detected in eight out of nine CQ-
neurons (). For a negative control, sample of bath solution was used (Bath); dilu
dicted product size for MrgprA3 (150 bp) and b-actin (302 bp). No product was d
(D and E) Representative traces from three different WTDRG neurons electropora
completely lost inWT neurons electroporated withMrgprA3 siRNA (D). However, t
to BAM8-22 (BAM). Twenty-four BAM8-22 sensitive neurons were analyzed. As
siRNA remained intact (ten CQ-sensitive neurons were analyzed) (E). But MrgprC
(F) The efficiency and specificity ofMrgprA3 siRNA were tested by cotransfection
MrgprC11. Western blot shows that MrgprA3 siRNA specifically knocked down
(G–M)MrgprA3 andMrgprX1 selectively rescued CQ responsiveness inMrgpr-cl
express MrgprA3-GFP protein is shown (G). Note the membrane and axon loca
neurons electroporated with MrgprA3 fired a train of APs upon CQ treatment (n =
elicited a few APs upon CQ treatment (I). MostMrgpr-clusterD/ neurons electr
generated a train of APs in response to CQ (J).
(K–M) Each figure shows typical calcium traces from three different neurons. All
response to CQ (1mM) but not BAM8-22 (2 mM) (K). AllMrgprA1-electroporatedm
portion responded to CQ (L). Electroporation of MrgprX1 rendered Mrgpr-cluste
CDISCUSSION
It has been known for a long time that both pain and itch are initi-
ated and modulated by small-diameter sensory neurons in DRG
(Caterina and Julius, 1999; Ikoma et al., 2006; Shim and Oh,
2008). Compared to pain, our knowledge of itch especially hista-
mine-independent itch at cellular and molecular levels is poor.
Here, we present evidence showing that sensory neuron-
specific Mrgprs are receptors mediating CQ-induced itch.
Mrgpr-clusterD/ mice exhibit a severe reduction in CQ-
induced scratching behavior, whereas histamine-mediated itch
and acute pain are completely normal. The residual CQ-induced
scratching behavior seen in mutant animals is likely due to an
indirect effect on skin sensory nerves. Both our behavioral data
from SASH mice and complete elimination of CQ-sensitive
neurons in Mrgpr-clusterD/ DRG support this notion and
suggest that the residual CQ-induced response in Mrgpr-
clusterD/ mice results from degranulation of skin mast cells
caused by the drug, a phenomenon observed in previous studies
(Green and Lim, 1989; Nosal et al., 1991).
Since Mrgpr members are highly homologous to each other,
especially the MrgprA subfamily (70%–80% identity), it is
surprising to find that only MrgprA3 shows strong activation
by CQ. The most divergent regions of MrgprAs are localized
to the extracellular loops, consistent with the differences in
their ligand preferences (Dong et al., 2001; Yang et al., 2005).
Bioinformatic analysis of Mrgpr sequences suggest that
positive selection likely accounts for the amino acid substitu-
tions in the extracellular domains (Choi and Lahn, 2003; Yang
et al., 2005). Interestingly, human MrgprX1 can respond to
both CQ and BAM8-22, whereas mouse MrgprA3 and
MrgprC11 are specific receptors for these two agonists, res-
pectively. The agonist selectivity of the mouse receptors
supports the conclusion made from statistical analysis that
adaptive evolution of Mrgpr family contributes to its expansion
in the mouse genome.Neurons
heads) and MrgprD (red). The white dashed line outlines the DRG.
he only tissues containingMrgprA3 areWTDRG and nodose ganglia. Notably,
leted in Mrgpr-clusterD/ mice.
ponsiveness to CQ (1 mM) established by calcium imaging (shown here are
responsive neurons (+) but was not detected in any of the 11 CQ-unresponsive
ted total DRG cDNA was used as positive control (DRG). Arrows indicate pre-
etected in RT controls from MrgprA3-expressing cells (n = 8).
ted with siRNAs in calcium-imaging assays. CQ-induced increase in [Ca2+]i was
hese neurons (normally express bothMrgprA3 andMrgprC11) are still sensitive
a control, CQ responsiveness in WT neurons electroporated with MrgprC11
11 siRNA completely abolished BAM8-22 sensitivity.
of HEK293 cells withMrgprA3 siRNA and expression constructs ofMrgprA3 or
the expression of MrgprA3 but not MrgprC11.
usterD/ DRG neurons. Visualization ofMrgpr-clusterD/ DRG neurons that
lization (arrowheads) of MrgprA3-GFP in DRG neurons. All Mrgpr-clusterD/
6) (H). Fewer than half ofMrgprA1-electroporated neurons (three out of seven)
oporated withMrgprX1 (five out of seven GFP-positive neurons recorded) also
MrgprA3-expressing Mrgpr-clusterD/ neurons showed increased [Ca2+]i in
utant neurons showed a strong response to FMRF (2 mM), whereas only a small
rD/ DRG neurons sensitivity to both CQ and BAM8-22 (M).
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Figure 7. CQ Responsiveness Defines a Specific Subpopulation of DRG Neurons
(A) CQ-responsive neurons represented a small population of DRG neurons that also responded to histamine (50 mM) and capsaicin (1 mM) with increased [Ca2+]i
monitored by calcium imaging.
(B) The total scratching bouts during the first 30 min after BAM8-22 intradermal injection (50 ml of 1 mM). WT mice exhibited significantly stronger scratching
responses after injection than did Mrgpr-clusterD/ littermates (n = 8 per genotype; *p < 0.05).
(C and D) As determined by calcium imaging, 3.6% ofWTDRG neurons responded to BAM8-22 (2 mM)with increased [Ca2+]i and all of them are also CQ-sensitive
(D), whereas Mrgpr-clusterD/ DRG neurons failed to respond to the drug (n = 3 per genotype) (C).
(E) The Venn diagram illustrates the relationships of histamine- (His), capsaicin- (Cap), chloroquine- (CQ), and BAM8-22- (BAM) responsive neurons in adult DRG.
The sizes of the circles are proportional to the sizes of the cell populations.
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According to our dose-response curves, EC50s of CQ for
MrgprA3 and human MrgprX1 are 27.55 ± 2.03 and 297.68 ±
2.10 mM, respectively. Although the concentration of CQ in
patient plasma is in the micromolar range, excretion of the
drug is quite slow and it is deposited in tissues in considerable
amounts (Adam et al., 2004; Evans et al., 2005; Onyeji andOgun-
bona, 2001). Since CQ binds strongly to melanin that is synthe-
sized by melanocytes, it accumulates at very high levels in the
skin and other pigmented tissues to reach high micromolar to
millimolar concentrations (Dencker et al., 1975; Olatunde,
1971; Sams and Epstein, 1965; Tanaka et al., 2004). The high
level of CQ (i.e., high micromolar to millimolar concentrations)
is also required to induce scratching behavior in mice based
on our and other group’s dose-response studies (data not
shown) (Green et al., 2006). In addition, patients prone to CQ-
induced itch accumulate higher concentrations of CQ in their
skin than those not prone to the side effect (Olatunde, 1971).
The different levels of CQ in the skin of the two groups are likely
due to different rates of metabolism of the drug (Onyeji and
Ogunbona, 2001). Besides the level of CQ in the skin, mouse
strain comparison and human familial clustering of itch studies
suggest that genetic variability also contributes to phenotypic
differences in CQ-induced itch (Ajayi et al., 1989; Green et al.,
2006). The high polymorphism seen in both mouse and human
Mrgpr genes may provide a molecular explanation for the vari-
ability in itch levels among different individuals (Dong et al.,
2001; Yang et al., 2005).
Our heterologous studies indicate that MrgprA3 is the major
receptor for CQ among the 12 deleted Mrgprs. Other Mrgprs
excluded in the cluster deletion are unlikely to be involved in
CQ signaling in DRG neurons because of the total loss of CQ
response in mutant DRG. Consistently, the percentage of CQ-
sensitive DRG neurons (i.e., 4%–5% of total DRG neurons)
matches that of MrgprA3-expressing cells as determined by
in situ hybridization on adult DRG sections (Liu et al., 2008).
More importantly, our single-neuron RT-PCR results indicate
that MrgprA3 expression correlates almost perfectly to CQ
responsiveness. Furthermore, both gain- and loss-of-function
studies firmly establish that MrgprA3 is required for CQ respon-
siveness in mice.
This small population of CQ-sensitive neurons marks a subset
of histamine- and capsaicin-responsive cells in DRG, and it has
a uniform cell size as compared to the total histamine-sensitive
population. According to different reports, the percentage of
histamine-sensitive cells in the DRG ranges from 15% to 40%
(Han et al., 2006; Kim et al., 2004; Nicolson et al., 2002). It is
unlikely that all of these cells are pruriceptive neurons. In fact,
human microneurography studies suggest the sensory fibers
that respond to histamine with sustained discharges are respon-
sible for itch, whereas those weakly activated by histamine are
involved in pain processing (Schmelz et al., 1997). The strong
histamine-responsive fibers comprise only a small portion of
all unmyelinated sensory fibers, and the majority of them are
heat responsive. Recent studies have shown that TRPV1,(F) WT adult DRG sections were doubly stained by in situ hybridization forMrgprA
cells (51 out of 55) express GRP. Arrowheads indicate MrgprA3/GRP-coexpress
All error bars represent the SEM.
Ca molecular sensor for capsaicin and heat, functions down-
stream of histamine receptors and is required for histamine-
induced DRG neuron activation and itch behavior (Shim et al.,
2007). These studies also raise the interesting possibility that
a subset of capsaicin- and heat-sensitive neurons mediates
itch. Therefore, it would be important to know whether the
4%–5% of total DRG neurons activated by CQ is selective for
itch. Activation of CQ-sensitive neurons by BAM8-22 through
MrgprC11 also induces scratching response, providing further
evidence that CQ-sensitive neurons may be itch-selective
neurons. Finally, overlap between MrgprA3- and GRP-express-
ing neurons in DRG leads us to propose a model for CQ signal
transduction: CQ directly activates a subset of primary sensory
fibers in the skin through MrgprA3. This leads to the release of
GRP into the dorsal horn of the spinal cord, where it activates
a subset of dorsal horn neurons through GRPR. Therefore, the
identification of Mrgprs as receptors for CQ may open new
avenues for the exploration of itch-selective neuron develop-
ment and function, as well as the development of novel anti-
itch drugs.EXPERIMENTAL PROCEDURES
Generation of Mrgpr-clusterD/ Mice
To delete a cluster ofMrgpr genes in the mouse germline, we constructed two
replacement vectors forMrgprA1 andMrgprB4, which reside on either end of
theMrgpr cluster. The entire ORFs of bothMrgprA1 andMrgprB4 are encoded
by a single exon. The arms of theMrgprA1 and MrgprB4 targeting constructs
were obtained by PCR amplification from 129/SvJ genomic DNA with the
Expand High Fidelity PCR System (Roche). Details of the generation of
Mrgpr-clusterD/ mice are available in the Supplemental Data.
Behavioral Studies
All behavioral tests were performed with an experimenter blind to genotype.
The mice were 2- to 3-month-old males (20–30 g) that had been backcrossed
to C57Bl/6 mice for at least ten generations. Rat studies were done with
4-week-oldCDanimals (Charles River Laboratories). All experimentswere per-
formed under the protocol approved by the Animal Care and Use Committee
of Johns Hopkins University School of Medicine. Pruritic compounds (i.e.,
histamine, compound 48/80, and CQ) were subcutaneously injected into the
nape of the neck after acclimatization, and scratching behavior was observed
for 30min. A bout of scratchingwas defined as continuous scratchmovements
with hind paws directed at the area around the injection site. Scratching
behavior was quantified by recording the number of scratching bouts at
5 min intervals over the 30 min observation period. Details for other behavior
assays are available in the Supplemental Data.
Cultures of Dissociated DRG Neurons
DRG from all spinal levels of 4-week-old mice or rats were collected in
cold DH10 medium and treated with enzyme solution at 37C. After tritura-
tion and centrifugation, cells were resuspended in DH10, plated on glass
coverslips coated with poly-D-lysine and laminin, cultured in an incubator
at 37C, and used within 24 hr. Details are available in the Supplemental
Data.
Electroporation of dissociated adult DRG neurons with Mrgpr-expression
constructs was carried out with the Mouse Neuron Nucleofector Kit (Amaxa
Biosystems) according to the manufacturer’s instructions. Electroporated
neurons were plated and cultured as described above.3 (blue) and immunostaining with anti-GRP antibody (brown). MostMrgprA3+
ing neurons. Arrows indicate MrgprA3+/GRP cells.
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Calcium Imaging
Neurons or HEK293 cells were loaded with fura 2-acetomethoxy ester
(Molecular Probes) for 30 min in the dark at room temperature or 45 min at
37C, respectively. After washing, cells were imaged at 340 and 380 nm excita-
tion to detect intracellular free calcium. Calcium-imaging assays were per-
formed with an experimenter blind to genotype. Each experiment was done at
least three times, and at least 100 cells (neurons or HEK293 cells) were analyzed
each time.
RNA Interference
MrgprA3 and MrgprC11 on-target siRNAs were purchased from Thermo
Scientific. 0.175 nmol MrgprA3 or MrgprC11 siRNA was electroporated into
WT DRG neurons, respectively. After 3 days of culture, neurons were replated
on glass coverslips for calcium imaging. HEK293 cells in 12-well plates were
cotransfected with 2 mg Mrgpr-expression constructs and 2 mg siRNA with
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol.
After 1 day of culture, cells were lysated for western blot.
Whole-Cell Current-Clamp Recordings of Cultured DRG Neurons
Neurons plated on coverslips were transferred into a chamber with the extra-
cellular solution. Patch pipettes had resistances of 2–4 MU. In current-clamp
recordings, action potential measurements were performed with an Axon
700B amplifier and the pCLAMP 9.2 software package (Axon Instruments).
Neuronswere perfusedwith 1mMCQ for 20 s. All experimentswere performed
at room temperature (25C). Details are available in the Supplemental Data.
In Situ Hybridization and Immunostaining
In situ hybridizationwas performed as previously described (Dong et al., 2001).
ForMrgprA3 and GRP double staining, after in situ hybridization forMrgprA3,
DRG sections were incubated overnight at 4C with Rabbit anti-GRP antibody
(Immunostar, 1:1000) in PBS/1% donkey serum/0.3% Triton X-100. After
washing twice in PBS, sections were incubated with biotinylated secondary
antibody (Jackson, 1:200) for 2 hr at room temperature and then washed twice
in PBS and incubated with ABCmix (Elite ABC kit, Vectastain) in PBS at RT for
1 hr. Sections were washed twice in PBS and incubated with 3,30-Diaminoben-
zidine/H2O2 in PBS for color development.
Single-Cell RT-PCR
Plated neurons with CQ responsiveness established by calcium imaging were
individually harvested into a glass pipette and transferred into PCR tube.
Reverse transcription was done by Super-Script III CellsDirect (Invitrogen) as
previously described (Kwong et al., 2008). Details for PCR conditions are avail-
able in the Supplemental Data.
Data Analysis
Data are presented as mean ± standard error of mean (SEM). Statistical
comparisons were made with an unpaired Student’s t test, and differences
were considered significant at p < 0.05.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)01492-5.
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